Browse the complete list of publications for PLCO.
Filter results of publications table below
| Title | PubMed | Authors | Journal | Year | Studies |
|---|---|---|---|---|---|
| Female Sex and Lung Cancer Risk In Two Large Screening Cohorts. | 40998130 | Charokopos A, Leiter A, Dua S, de-Torres JP, Mhango G, Zulueta JJ, Powell C, Sigel KM, Federman AD, Wisnivesky JP | Respir Med | 2025 | NLST, PLCO |
| Contrasts in colorectal cancer incidence and mortality in screening trials of sigmoidoscopy versus colonoscopy (NordICC). | 40971678 | Meester RGS, Miller EA, Pinsky PF, Schoen RE, Ladabaum U | J Natl Cancer Inst | 2025 | PLCO |
| Prostate-Specific Antigen Levels Among Participants Receiving Annual Testing. | 40965920 | Pickersgill NA, Peré MM, Vertosick EA, Nalavenkata S, Vieira Lima Aguiar Melão B, Vickers AJ, Lilja H, Eastham JA, Carlsson SV | JAMA Oncol | 2025 | PLCO |
| Oral Bacterial and Fungal Microbiome and Subsequent Risk for Pancreatic Cancer. | 40965868 | Meng Y, Wu F, Kwak S, Wang C, Usyk M, Freedman ND, Huang WY, Um CY, Gonda TA, Oberstein PE, Li H, Hayes RB, Ahn J | JAMA Oncol | 2025 | PLCO |
| Metabolomic Biomarkers and Signature of Ultra-processed Foods Intake and Cardiovascular Morbidity and Mortality. | 40950491 | Wang L, Yang J, Chen J, Rebholz CM, Shu XO, Shrubsole MJ, Gupta DK, Lipworth L, Ma S, Dai Q, Zheng W, Yu D | medRxiv | 2025 | PLCO |
| Challenging the Status Quo Regarding the Benefit of Chest Radiographic Screening. | 40936165 | Yankelevitz DF, Yip R, Henschke CI | J Thorac Imaging | 2025 | PLCO |
| Ten-Year Trends in Digital Rectal Exam Results and Prostate Cancer Detection: Insights from the PLCO Trial. | 40910103 | Guan K, Dahman B, Tan SH, Chen D, Waters AJ, Chesnut GT, Kern SQ, Ahmed AE | Res Rep Urol | 2025 | PLCO |
| MIXED MODELING APPROACH FOR CHARACTERIZING THE GENETIC EFFECTS IN A LONGITUDINAL PHENOTYPE. | 40893136 | Zhang P, Albert PS, Hong HG | Ann Appl Stat | 2025 | PLCO |
| Insulinemic and Inflammatory Dietary Patterns and Colorectal Cancer Risk: A Dietary Data Harmonization Study of One Million Participants in the COMETS Consortium. | 41167399 | Shi N, Hoobler R, Harewood R, Toland AE, Albanes D, Bouras E, Gunter MJ, Liao LM, Moore SC, Ricceri F, Rotter JI, Sinha R, Stolzenberg-Solomon R, Tjønneland A, Wood AC, Yu D, Playdon MC, Tabung FK | Am J Clin Nutr | 2025 | PLCO |
| Missed colorectal cancer diagnosis by screening colonoscopy based on the PLCO cancer screening trial. | 41039049 | Li Y, Xiong H, Liang T, Liu Y, He L, Tan W, Wang Y, Qiu X, Zhong B, Xie C, Li J | Int J Colorectal Dis | 2025 | PLCO |
| Artificial intelligence defines spatial patterns of tumor-infiltrating lymphocytes highly associated with outcome - a pan-GI cancer study. | 41033282 | Chen C, Mejbel HA, Pathak T, Krasinskas A, Reid M, Corredor G, Fu P, Willis JE, Madabhushi A | ESMO Open | 2025 | PLCO |
| Dietary Glycemic Index, Glycemic Load, and Risk of Lung Cancer: A Population-Based Cohort Study. | 41285602 | Wang J, Li L, Wang K | Ann Fam Med | 2025 | PLCO |
| Adherence to the 2018 World Cancer Research Fund/American Institute for Cancer Research Cancer Prevention Recommendations and risk of lifestyle-related cancers in the prostate, lung, colorectal, and ovarian cancer screening trial. | 41261199 | Malcomson FC, Shams-White MM, Reedy J, Huang WY, Moore SC, Loftfield E | BJC Rep | 2025 | PLCO |
| Dynamic prediction by landmarking with data from cohort subsampling designs. | 41359305 | Chang Y, Ivanova A, Albanes D, Fine JP, Shin YE | Stat Methods Med Res | 2025 | PLCO |
| Prediagnostic Serum Concentrations of Per- and Polyfluoroalkyl Substances and Risk of Endometrial Cancer in a US Cohort. | 40262115 | Madrigal JM, Trabert B, Medgyesi DN, Fisher JA, Calafat AM, Cook Botelho J, Kato K, Albert PS, Silverman DT, Hofmann JN, Jones RR | Environ Health Perspect | 2025 | PLCO |
| Circulating per- and polyfluoroalkyl substances and liver cancer risk: a nested case-control analysis of individual participant data from 12 prospective cohorts. | 40397817 | Watling CZ, Petrick JL, Graubard BI, Zhang X, Barnett MJ, Buring JE, Chen Y, Eliassen AH, Gaziano M, Kang JH, Koshiol J, Huang WY, Lee IM, Moore SC, Mucci LA, Neuhouser ML, Newton CC, Palmer JR, Rosenberg L, Sesso HD, Shrubsole M, Tinker L, Triplett… | Environ Health Perspect | 2025 | PLCO |
| Long-chain sulfatide enrichment is an actionable metabolic vulnerability in intraductal papillary mucinous neoplasm (IPMN)-associated pancreatic cancers. | 40268349 | Chen Y, Ballarò R, Sans M, Thege FI, Zuo M, Dou R, Min J, Yip-Schneider M, Zhang J, Wu R, Irajizad E, Makino Y, Rajapakshe KI, Rudsari HK, Hurd MW, León-Letelier RA, Katayama H, Ostrin E, Vykoukal J, Dennison JB, Do KA, Hanash SM, Wolff RA, Guerrero… | Gut | 2025 | PLCO |
| Integrated Metabolomics and Spatial Transcriptomics of Cystic Pancreatic Cancer Precursors Reveals Dysregulated Polyamine Metabolism as a Biomarker of Progression. | 40184234 | León-Letelier RA, Chen Y, Dou R, Irajizad E, Yip-Schneider MT, Wu R, Ejaz R, Rudsari HK, Li Y, Spencer R, Ballarò R, Vykoukal J, Hurd M, Dennison JB, Do KA, Maitra A, Zhang J, Hanash S, Schmidt CM, Fahrmann JF | Clin Cancer Res | 2025 | PLCO |
| Association between prediagnostic serum metabolites and pancreatic ductal adenocarcinoma risk in two prospective cohorts. | 40401725 | Zhang T, Moore SC, Fu S, Wang X, Albanes D, Weinstein SJ, Yu K, Stolzenberg-Solomon RZ | Int J Cancer | 2025 | PLCO |
| Elevated Alcohol Consumption and Chronic Inflammation Predict Cardiovascular Risk Among Black Americans: Examination of a Dual-Risk Model Using Epigenetic Risk Markers. | 41133715 | Beach SRH, Philibert RA, Ong ML, Lei MK, Ye K | Epigenomes | 2025 | PLCO |